Latham & Watkins’ Charles Ruck: “The second you think you have it all figured out, it’ll shift”
On the sidelines of the Jefferies Global Healthcare Conference in London, Latham & Watkins corporate chair Charles Ruck talks tough regulation in Europe and the US, most favored nation pricing, when biotechs should reveal their targets, and what tells him a company will go far.
